Beconase and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Beconase (beclomethasone dipropionate) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include cholestasis among females and chronic obstructive airways disease among males.

The phase IV clinical study analyzes what interactions people have when they take Beconase and Cipro. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Beconase?

Beconase has active ingredients of beclomethasone dipropionate. It is often used in asthma. eHealthMe is studying from 1,224 Beconase users. Check the latest studies of Beconase.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

On Jul, 12, 2026

22 people who take Beconase and Cipro together, and have interactions are studied.

What are the common drug interactions of Beconase and Cipro, by gender? *:

female:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Haemorrhage (bleeding)
Hepatic failure (liver failure)
Syncope (loss of consciousness with an inability to maintain postural tone)
Tinnitus (a ringing in the ears)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Retching (strong involuntary effort to vomit)
Urticaria (rash of round, red welts on the skin that itch intensely)
Cushingoid (obesity and weakening of the muscles)
Dizziness

male:

Chronic obstructive airways disease
Ear pain
Wound dehiscence (a surgical incision reopens either internally or externally)
Wound drainage increased
Arterial injury
Blood urine
Dehydration (dryness resulting from the removal of water)
Hyperkalaemia (damage to or disease of the kidney)
Inflammation
Joint swelling

What are the common drug interactions of Beconase and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

30-39:

n/a

40-49:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Haemorrhage (bleeding)
Hepatic failure (liver failure)
Syncope (loss of consciousness with an inability to maintain postural tone)
Tinnitus (a ringing in the ears)
Drug toxicity
Headache (pain in head)
Hepatitis (inflammation of the liver)
Retching (strong involuntary effort to vomit)
Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

Abdominal pain
Collapse (sudden functional breakdown)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Insomnia (sleeplessness)
Oedema peripheral (superficial swelling)
Sweating increased (excess sweating)
Wound dehiscence (a surgical incision reopens either internally or externally)
Wound drainage increased
Arterial injury

60+:

Chronic obstructive airways disease
Ear pain
Drug hypersensitivity
Hyperkalaemia (damage to or disease of the kidney)
Joint swelling
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nausea (feeling of having an urge to vomit)
Somnolence (a state of near-sleep, a strong desire for sleep)
Tendon disorder (disease of tendon)
Vomiting

* Approximation only. Some reports may have incomplete information.

Do you take Beconase and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously